MOH — authorised 31 July 2014
- Marketing authorisation holder: BOEHRINGER INGELHEIM
- Status: likely_approved
🇮🇱 Striverdi Respimat in Israel
MOH authorised Striverdi Respimat on 31 July 2014
Marketing authorisation
Striverdi Respimat in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in Israel
Frequently asked questions
Is Striverdi Respimat approved in Israel?
Yes. MOH authorised it on 31 July 2014.
Who is the marketing authorisation holder for Striverdi Respimat in Israel?
BOEHRINGER INGELHEIM holds the Israeli marketing authorisation.